Skip to content
Clinical Trials – home
Verifiedinfo

MVZ Onko Medical GmbH Hannover

Germany Pelikanplatz 23, 30177 Hanover, Germany

  • 3 trials recruiting
  • Ovarian cancer · Hormone receptor positive HER2 negative breast cancer · Malignant peritoneal neoplasm
  • Adult patients

About Specializations

MVZ Onko Medical GmbH Hannover in Hanover, Germany specialises in clinical trials of conditions such as Ovarian cancer, Hormone receptor positive HER2 negative breast cancer, Malignant peritoneal neoplasm, Fallopian tube cancer, and other specialisations. This site conducts important research.

Main research areas of the site

Oncology

The medical center is at the forefront of oncology research, with a particular focus on triple-negative breast cancer. This challenging subtype of breast cancer lacks the three most common types of receptors known to fuel most breast cancer growth, making it more difficult to treat.

  • Triple-Negative Breast Cancer
  • Neoadjuvant Chemotherapy
  • Immunotherapy

Through innovative clinical trials, the center is exploring the efficacy of combining atezolizumab, an immunotherapy drug, with traditional chemotherapy regimens to improve event-free survival rates in patients. This research is pivotal in developing new therapeutic strategies that could significantly enhance patient outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Pelikanplatz 2330177 HanoverGermany
Recruiting now
3 trials
Conditions studied
8
Partner status
Verified

More sites in HanoverGermany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

9 clinical trials

Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:BeOne Medicines I GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Glatiramer Acetate
  • Sponsor:Genmab A/S
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:AGO Research GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Fondazione Michelangelo

Ovarian cancer

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Novartis Pharma AG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Doxorubicin
  • Sponsor:Merck Sharp & Dohme LLC

Neoplasm malignant

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:NSABP Foundation Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.